# Evaluation of Patients With Refractory Dermatomyositis Using [18F] FAPI-74 PET/MRI Imaging

> **NCT06568783** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Farshad Moradi** · enrollment: 21 (estimated)

## Conditions studied

- Refractory Dermatomyostitis

## Interventions

- **DRUG:** [18F]-FAPI-74

## Key facts

- **NCT ID:** NCT06568783
- **Lead sponsor:** Farshad Moradi
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12
- **Primary completion:** 2027-10
- **Final completion:** 2028-10
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2024-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06568783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06568783, "Evaluation of Patients With Refractory Dermatomyositis Using [18F] FAPI-74 PET/MRI Imaging". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06568783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*